These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32938441)

  • 1. Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management.
    Li S; He Z; Luo Y; Ji Y; Luo G; Fang Q; Gao Y
    BMC Pregnancy Childbirth; 2020 Sep; 20(1):539. PubMed ID: 32938441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perinatal risk factors associated with severity of haemolytic disease of the foetus and newborn due to Rhc maternal-foetal incompatibility: A retrospective cohort study.
    Franchinard L; Maisonneuve E; Friszer S; Toly Ndour C; Huguet-Jacquot S; Maurice P; Mailloux A; Cortey A; Jouannic JM
    Vox Sang; 2022 Apr; 117(4):570-579. PubMed ID: 34743337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F; Moiz B; Kamran N
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
    Roubalová L; Lubušký M
    Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between previous maternal transfusions and haemolytic disease of the foetus and newborn mediated by non-RhD antibodies.
    Dajak S; Culić S; Stefanović V; Lukačević J
    Blood Transfus; 2013 Oct; 11(4):528-32. PubMed ID: 23522892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal and Obstetrical Outcomes of Pregnancies Complicated by Alloimmunization.
    Bahr TM; Tweddell SM; Zalla JM; Dizon-Townson D; Ohls RK; Henry E; Ilstrup SJ; Kelley WE; Ling CY; Lindgren PC; O'Brien EA; Christensen RD
    Pediatrics; 2024 Jun; 153(6):. PubMed ID: 38784990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn.
    Sonneveld ME; Koelewijn J; de Haas M; Admiraal J; Plomp R; Koeleman CA; Hipgrave Ederveen AL; Ligthart P; Wuhrer M; van der Schoot CE; Vidarsson G
    Br J Haematol; 2017 Feb; 176(4):651-660. PubMed ID: 27891581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Title: Effect of multiple maternal red cell alloantibodies on the occurrence and severity of Hemolytic Disease of the Fetus and Newborn.
    Singh B; Chaudhary R; Katharia R
    Transfus Apher Sci; 2021 Feb; 60(1):102958. PubMed ID: 33039278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with persistence of red blood cell antibodies in woman after pregnancies complicated by fetal alloimmune haemolytic disease treated with intrauterine transfusions.
    Verduin EP; Brand A; van de Watering LM; Claas FH; Oepkes D; Lopriore E; Doxiadis II; Schonewille H
    Br J Haematol; 2015 Feb; 168(3):443-51. PubMed ID: 25244566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A descriptive single-centre experience of the management and outcome of maternal alloantibodies in pregnancy.
    Chatziantoniou V; Heeney N; Maggs T; Rozette C; Fountain C; Watts T; Harrison C; Pasupathy D; Sankaran S; Kyle P; Robinson S
    Transfus Med; 2017 Aug; 27(4):275-285. PubMed ID: 28608631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemolytic disease of the fetus and newborn due to multiple maternal antibodies.
    Markham KB; Rossi KQ; Nagaraja HN; O'Shaughnessy RW
    Am J Obstet Gynecol; 2015 Jul; 213(1):68.e1-68.e5. PubMed ID: 25644438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and clinical significance of red cell antibodies in pregnancy - A prospective study from India.
    Das S; Shastry S; Rai L; Baliga PB
    Indian J Pathol Microbiol; 2020; 63(2):241-246. PubMed ID: 32317523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B; Zupańska B
    Ginekol Pol; 2003 Jan; 74(1):48-54. PubMed ID: 12715437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
    Smith HM; Shirey RS; Thoman SK; Jackson JB
    Immunohematology; 2013; 29(4):127-30. PubMed ID: 24689681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of haemolytic disease of the foetus and newborn caused by Alloantibody D and Jka in a Rhesus D negative Nigerian woman: Justification for the implementation of universal access to prophylaxis and evidenced-based best practices.
    Erhabor O; Azachi WB; Tosan E
    Hum Antibodies; 2020; 28(3):245-252. PubMed ID: 32417769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-M induced severe haemolytic disease of foetus and newborn in a Malay woman with recurrent pregnancy loss.
    Mohd Nazri H; Noor Haslina MN; Shafini MY; Noor Shaidatul Akmal AR; Rapiaah M; Wan Zaidah A
    Malays J Pathol; 2017 Apr; 39(1):73-76. PubMed ID: 28413208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, specificity and risk of red blood cell alloantibodies among hospitalised Hubei Han Chinese patients.
    Xu P; Li Y; Yu H
    Blood Transfus; 2014 Jan; 12(1):56-60. PubMed ID: 24333071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.